Otipax® (Otipax®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspear drops
Composition:

1 g of solution contains:

active ingredients: lidocaine hydrochloride 10 mg, phenazone 40 mg;

Excipients: sodium thiosulfate 1 mg, ethanol 221.8 mg, glycerol 709 mg, water 18.2 mg.

Description:Transparent, colorless or yellowish solution with the smell of alcohol.
Pharmacotherapeutic group:Anti-inflammatory agent for topical application
ATX: & nbsp
  • Combined preparations
    • Pharmacodynamics:

    Fenazone has anti-inflammatory and analgesic effect.

    Lidocaine has a local anesthetic effect.

    Pharmacokinetics:

    The drug does not penetrate the body with an intact tympanic membrane.

    Indications:

    Local symptomatic treatment and anesthesia in children from birth and adults with:

    - average otitis media in an acute period at the time of inflammation;

    - Otitis as a complication after the flu;

    - barotraumatic edema.

    Contraindications:

    - Hypersensitivity to the components of the drug;

    - perforation of the tympanic membrane.

    Carefully:

    It is necessary to make sure the integrity of the tympanic membrane before applying the drug. In case of using the drug with a perforated tympanic membrane, the drug can come into contact with the organs of the middle ear and lead to complications.

    Information for athletes: the preparation contains an active ingredient capable of giving a positive reaction during doping control.

    Pregnancy and lactation:

    Restrictions on the use of the drug during pregnancy and during breastfeeding are absent under the condition of an intact tympanic membrane.

    Dosing and Administration:
    Otipaks® is applied topically, by digging into the external auditory meatus 2-3 times a day for 3-4 drops.

    To avoid contact of the cold solution with the auricle, the bottle should be warmed in the palms before use.

    The duration of Otypax® is no more than 10 days, after which the prescribed treatment should be reviewed.

    After the first opening of the vial, the drug should be used within 6 months. Do not use after the expiration date printed on the package.

    Side effects:

    There is a risk of allergic reactions, irritation and hyperemia of the auditory canal.

    Interaction:

    At present, there is no information on interactions with other drugs.

    Form release / dosage:

    Ear drops, 10 mg + 40 mg.

    Packaging:

    For 16 g in a bottle of amber glass with a screw cap and a dropper, packed in a PVC blister / paper,placed in a cardboard box with a nested instruction for medical use.

    Storage conditions:

    Store at a temperature not exceeding 30 FROM.

    Keep out of the reach of children.

    Shelf life:

    5 years.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N011568 / 01
    Date of registration:05.10.2011
    Expiration Date:Unlimited
    The owner of the registration certificate:BIOCODEX BIOCODEX France
    Manufacturer: & nbsp
    BIOCODEX France
    Representation: & nbspBIOCODEX BIOCODEX France
    Information update date: & nbsp15.06.2017
    Illustrated instructions
      Instructions
      Up